Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study - Franchi, F; Ortega-Paz, L; Rollini, F (EuroIntervention, 2023)